Month: January 2012

BENEO presents new solutions sweeteners with ISOMALT, Stevia and PalatinoseTM in the international fair of confectionery in 2012

|

BENEO presents new solutions sweeteners with ISOMALT, Stevia and PalatinoseTM in the international confectionery fair of 2012

29 January to 1 February 2012, Cologne, Hall 10.2, Stand F62

Madrid, January 2012- BENEO, one of the leading manufacturers of functional ingredients, will present a series of new solutions sweeteners in the edition of this year of the international confectionery fair (ISM). These solutions include samples of candy sugar-free flavored herbs made with ISOMALT and Stevia, as well as a new concept of bubble gum that, for the first time presents the BENEO (Isomaltulose) combined with Stevia PalatinoseTM *. Combining functional load sweeteners of BENEO with Stevia, can be found several nutritional and health benefits without compromising the taste and palatability of the final product.

Chewing gum with PalatinoseTM (and Stevia)

In the ISM, BENEO will present the ’first’ gum with PalatinoseTM and Stevia – chewing gum does not cause tooth decay which is entirely palatable. The combination of these ingredients reveals a sweetness resembles the sugar that successfully masks the taste to licorice sometimes associated with Stevia. With the growth of the market of the children’s chewing it represents 12.2 per cent of the value of the total market of gum worldwide (Euromonitor 2011), and product launches with Stevia which have more than tripled in 2010-2011 worldwide according to Mintel, the natural evolution is the combination of the benefits of Stevia with the nutritional and technical benefits of the sugar does not cause BENEO, PalatinoseTM caries.

The next generation of BENEO sugar can be processed as sucrose. Conservation tests have shown that both the texture of the nucleus and the crunch are similar to the chewing of sucrose. However, unlike sucrose, PalatinoseTM has a low Glycemic and not index causes tooth decay. Its slow dissolution kinetics helps release the flavors for a long time and its very low higroscopicidad increases the time for the conservation of the gum. In addition, the use of PalatinoseTM in the gum allows retaining the shape of the kernel immediately, while other gum cores have to be stored for a specified period of time to produce similar results.

Caramel sugar with ISOMALT and Stevia

In the ISM, BENEO also presented a candy without sugar-flavored herbs made with ISOMALT and Stevia. The combination of ISOMALT and Stevia promotes a wide variety of flavors without any negative aftertaste like that sometimes is associated with Stevia. This is due to the fact that ISOMALT enhances both the fruit flavors and subtle flavours and presents good stability, which guarantees that the taste of the product is not altered with the passage of time. The combination of ISOMALT and Stevia not only guarantees a profile of taste refined during the lifetime of the product, but it also produces other nutritional and technical benefits that include: without sugar, low Glycemic, does not cause tooth decay, low in calories and the sugar-like sweetness.

Both PalatinoseTM and ISOMALT are obtained from sugar beet and possess a sweetener similar profile. Recently, the European authority on food security (EFSA) has approved its glucémicos benefits and dental health. Both sweeteners cargo offer manufacturers an alternative to sugar, while providing benefits to consumers.

’ consumers and manufacturers expect a healthy alternative to have a taste, functionality and a volume similar, exactly the same that are used to experiment with sugar. ” «Thanks to the work we have done to develop the optimum sweetening matter profile by combining ISOMALT and PalatinoseTM with Stevia, we can now get a series of nutritional benefits, taste and health», says Rudy Wouters, Vice President of the BENEO-Technology Center.

The obtaining of sensations of flavors balanced with ISOMALT and Stevia was made possible by BENEO-Technology Center. This newly created Knowledge Center specialists have worked closely to overcome the challenges associated with the formulations with Stevia. The experience of BENEO in the combination of their load with Stevia sweeteners favours the development of healthy products with a balanced sweetening and added benefits.

Read More

Studies in development related deficit of vitamin D with the onset of allergic diseases

|

studies in developing related deficit of vitamin D with the onset of allergic diseases

GlaxoSmithKline (GSK) organizes the VIII meeting controversies and developments in allergy (CYNA)

– for the Dra Erika Von Mutius, Director of the Department of asthma and allergy in the children’s Hospital of the University of Munich, there are certain optimal germs in the environment that could protect the patient of asthma and other allergies

– Dr Ian Pavord of the Institute of Lung Health in Leicester, stressed the importance of recognizing the different phenotypes in asthma and COPD (chronic obstructive pulmonary disease) to properly classify patients and administering the most appropriate treatments

Madrid, January 2012.- close all Spain 450 Allergists have attended the VIII Edition of the dispute resolution meeting and developments in allergy (CYNA)organized annually by GlaxoSmithKline (GSK) and scientifically coordinated by DRA. Montserrat Fernandez Rivas, Prof. j. Luis Prieto Andrew and Dr. Joaquín Sastre Domínguez. The meeting has again proved a great success because of the high scientific level of invited speakers and topical of the issues addressed.

Thus, this year’s Edition has been involving reputed DRA. Erika von Mutius, Director of the Department of asthma and allergy of the University children’s Hospital of Munich and the research group in asthma and allergy of the University. In his speech, “ the development of asthma and allergy: hygiene theory ”, has pointed out that this theory has been more than 20 years to evolve. Currently is based on the studies on farms to check that in places where there are a large number of microorganisms in the air and environment children would be protected from the development of allergy. Therefore at this time, the research aims to demonstrate that in environments with many germs, some optimal colonizarían respiratory tract, so that harmful germs did not have the opportunity to do so.

This expert has participated in several studies on farms and has stated that one of its objectives is the full understanding of this process “ then so could find ways to prevent it ”. So far, and in pursuit of this prevention, what has been achieved in their research is to prevent asthma in mice, managing optimal germs (Lactococus lactis and Acinetobacteria) of the stables of animal intranasal.

New theory of vitamin D deficiency

For its part, Prof. Luis Prieto Andrew, Professor of the Department of Medicine of the Faculty of medicine and dentistry at the University of Valencia, and comoderador of the table on “ epidemiology and asthma ”, highlighted the new theory of the deficit of vitamin D. “ are developing a series of studies on the relationship between vitamin D deficiency)(that occurs in the northern countries, where there is less exposure to the Sun) and the development of allergic diseases, with a statistically significant and obvious relationship. It is a theory that lies at the stadiums early development, but for now we know that a relationship exists between the two. Objective that occurs at the moment is to check if solving the problems of vitamin D in societies where there is no sun, you get prevent disease ”, said the specialist.

In addition, one of the main presentations of the meeting has been given by Dr. Ian Pavord, the Department of respiratory medicine, thoracic surgery and allergy of the University Glenfield Hospital in Leicester (United Kingdom), which was who first identified the phenotypes of asthma and qualify them so that they would have relevance in the management of patients. The British expert in respiratory diseases has highlighted the implications clinical recognize the different phenotypes in asthma and COPD, and properly classify patients and individualize your treatment.

Also, the meeting has been with the participation of Dr. Joaquín Sastre Dominguez, Chief of the service of allergy of the Fundación Jiménez Díaz of Madrid, which has acted as comoderador of the round table on “ allergy to implants ”, latest news item. She raised the challenge to predict patient allergies to metal implants and adverse reactions to implant cosmetics through previous studies, identifying risk groups. “ Is common to find people with allergies to metals. In women the incidence of allergy to nickel reaches almost 10 per cent but increasingly there are more men that develop because of new social customs as the “ piercing ”, said Dr. Sastre.

On the other hand, the DRA. Montserrat Fernandez Rivas, alergóloga of the Hospital Clínico San Carlos in Madrid, has coordinated the presentations on “ allergy drugs ”. On the one hand has dealt with allergy to biological medicinal products, given his growing, and on the other hand use drugs that are exceptional but of considerable gravity serious skin reactions. The Bureau has discussed on skin testing or laboratory that should be done to diagnose patients.

Read More

Elsevier launches the new edition of his, one of the most used in the world of Anatomy

|

Elsevier launches the new edition of his, one of the most used in the world of Anatomy

-The 23rd edition of Sobotta Atlas of human anatomy, is completely renewed, adapted to the new times, new technologies, and of course, to the new needs of the students.

Madrid, January of 2012. The study, complex, and arduous of anatomy is essential to the need for highly structured content and valuable training to facilitate learning.

Therefore, Elsevier offers a new edition of the classic Sobotta Atlas of human anatomy, one of the texts of Anatomy most used in the world, which at its 23rd edition appears totally renewed, adapted to the new times, new technologies, and of course, the new needs of the students. Since the first edition in 1904, this Atlas has become a reference book for teaching and study of the human anatomy.
“ Sobotta has evolved and grown in volume, new prints have been added and new images of different diagnostic techniques have been incorporated by image. In this sense, one of the most important developments for the reader is the incorporation of a brief explanation of the image that is not limited simply to the wording of the same, as it was the case up to now, but it also sets out how has come to her through the process of dissection, or what are the most important data relating to the image displayed and may serve to clarify concepts ”, explains Dr. Víctor Götzens, Professor of human anatomy. Faculty of medicine, University of Barcelona.

The 23rd edition of Sobotta is structured in the following way: volume 1 – general Anatomy and locomotor-, volume 2 – organs internally- and volume 3 – head, neck, and neuroanatomy. Also included is an offprint, which incorporated tables of muscles, joints, and nerves. It consists of more than 1,000 pages and 1,500 detailed color illustrations.

This edition offers a number of advantages that provide greater conceptual clarity and balance of iconography and texts. These improvements are based on a design entirely renovated and reorganized; reduction in the level of marking of the figures, highlighting in bold the most important; explanatory text boxes in more complex structures; and more homogeneous organization of chapters, both indoors and at the beginning of the chapters.

www.e-Sobotta.com

www.e-sobotta.com (in English), is one of the great innovations of this new edition. It’s an easy navigability and web use, which becomes a tool of great educational value. This multimedia content is based on a large number of downloadable images (over 1,500), a collection of large size autoimprimibles illustrations (more than 300), and a tool for self-assessment of high educational value.

“ The current information technology is widely focused towards the image and Sobotta could not be outdone. Why has incorporated access over the network to a base of anatomical, clinical, images of diagnostic image, etc., to supplement to his in the most complete tool ”, points out Dr. Götzens.

For more information: http://www.youtube.com/watch?v=eC_bF4GhNJU

Spain Elsevier

Spain Elsevier is part of the group, Elsevier, global leader in technical editing in medicine and health sciences. After the unification of their publishing books and biomedical journals with Masson Doyma funds respectively, Elsevier Spain became integral partner of the health sciences community. Currently edit a hundred magazines which include more than 70 científico-médicas societies official headers. Its editorial Fund of medical books has works by outstanding local authors and translations of major international references.

Elsevier Group

With headquarters in Amsterdam and a workforce of more than 7,000 people worldwide, the Elsevier Group is a global leader in technical editing in medicine and health sciences. It is formed by publishers of great tradition and prestige as W.B. Saunders, Mosby, Churchill Livingston, Butterworth Heinemann and Hanley & Belfus.

Working with the most respected scientists and researchers worldwide, Elsevier has among its publications with excellent professional references, known and used by specialists from around the world, as well as texts and support materials more employees and consulted by students and medical professionals. The company works in partnership with the communities of health professionals and Science around the world and publishes over 2,000 journals, which include The Lancet and Cell, and about 20,000 books, including works of reference of funds from Mosby and Saunders.

Read More

12Th joint meeting of winter of the Spanish society for Pneumology and thoracic surgery

|

Winter of the Spanish society for Pneumology and thoracic surgery joint meeting XII

February 4 global cancer _Día

genetic fingerprint will be key in new treatments for lung cancer

-lung cancer accounting for 13.4% of new cases of cancer and that is why most frequent mortality cancer.

-En Spain die about 18,000 people a year by its cause, some 16,000 men and some 2,000 women.

-overall survival of lung cancer is 15% to 80% of breast cancer, 65% of colon cancer.

Zaragoza, January 2012.- Lung cancer will be one of the protagonists in the XII joint meeting of areas of the Spanish society for Pneumology and thoracic surgery, held on 10 and 11 February in Zaragoza. One of the highlights will be progress towards personalized therapy for lung cancer through genetic analysis of the samples and their impact on the prognosis and treatment, in a round table moderated by Rosa Cordovilla neumóloga.

Lung cancer is one of the most aggressive and causing a greater number of deaths followed by colon-rectal cancer. Globally, it is the first cause of death from cancer among men and among women even beating breast cancer. Spain diagnosed around a 20,000 cases per year and is the cause of the death of 8.3 per cent of Spaniards (1 in 12 men dies of a lung cancer in Spain) and 1.3% of women. In our country more die from lung cancer that cancers of breast, colon and prostate together, being overall survival of lung cancer at age 5 of just 15% of patients.

The response to this aggression by health professionals is in search of new strategies against cancer through “ personalised treatments ” for each patient according to their genetic characteristics. It’s identifying “genetic fingerprints” in cancer cells of the patients and propose a specific treatment based on genetic characteristics of the disease and its response to drug therapy, improve survival and minimize side effects, with the consequent improvement in the quality of life.

“ Generate in time and in detail, not only information on cancer, but on the factors influencing the response to treatment, will offer a treatment personalized to each patient in order to improve the prognosis and quality of life, at the same time, that reduce the ineffective therapies and costs arising from the same ” explains the DRA. Rosa Cordovilla.

To get to the personalized treatments, the first step is to understand the genetic changes that occur in tumor cells that depend on the tissue of origin, of the type of cancer and random. From this information, the second step is to design a specific drug for “ correct each of these failures that we find in the genome of cancer cell ” explains the DRA. Cordovilla. Finally, will have to search for clues to determine their sensitivity to different compounds, to choose the most effective in the DNA of the patient.

In recent years, made significant progress thanks to the significant improvements in techniques that can read the genes in the cells. Currently, (NSCLC) non-small cell lung cancer may be classified into different types based on genetic alterations of the tumor. For each of these types already specific customized therapies directed against these alterations can be administered.

So, there are two types of tumor genetic alterations and two types of specific oral treatments against them which have already been widely contrasted. Firstly, the mutation of the EGFR gene found in 16% of the Western population and more frequently in women patients, not smokers, Asian and adenocarcinoma of the lung. This mutation predicts response to a treatment called tyrosine kinase of EGFR inhibitor. Various studies have shown that in cell lung cancer patients not small and mutation of the EGFR gene in the tumor tissue, administering such treatment improves survival and keeps a good quality of life.

On the other hand, it has been found that you between 2-7% of patients with non-small cell lung cancer has another genetic alteration which consists a reordering and merging of two fragments of chromosome 2 (ALK and EML4). It is more common in male patients, young people, non-smoking and histology of adenocarcinoma. This type of patient is managing an oral drug that inhibits this genetic alteration and prolongs survival.

“ Both treatments are administered by mouth, are very specific and, therefore, are better tolerated that they have fewer side effects than the classical chemotherapy ” points the DRA. Cordovilla. These new custom strategies are getting improve survival and minimize side effects, with the consequent improvement in the quality of life of patients

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips